Patents by Inventor Mitsuko Miyamoto

Mitsuko Miyamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for chronic renal failure
    Patent number: 8575175
    Abstract: The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a drug comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof, which drug is useful not only for amelioration of renal function, but also for amelioration of anemia, activation of SOD and excretion of uremic substances.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: November 5, 2013
    Assignee: Toray Industries, Inc.
    Inventors: Fuko Matsuda, Katsuhiko Iseki, Hajimu Kurumatani, Mitsuko Miyamoto
  • THERAPEUTIC AGENT FOR CHRONIC RENAL FAILURE
    Publication number: 20110178103
    Abstract: The present invention aims to provide a therapeutic agent for chronic renal failure, comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof. That is, the present invention provides provision of a drug comprising as an effective ingredient a compound represented by General Formula (1) or a pharmaceutically acceptable salt thereof, which drug is useful not only for amelioration of renal function, but also for amelioration of anemia, activation of SOD and excretion of uremic substances.
    Type: Application
    Filed: July 23, 2009
    Publication date: July 21, 2011
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Fuko Matsuda, Katsuhiko Iseki, Hajimu Kurumatani, Mitsuko Miyamoto
  • CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES
    Publication number: 20100189679
    Abstract: A cross-linked polyallylamine or an acid addition salt thereof has both high phosphate adsorption capability and low degree of swelling, and a medical use thereof. The cross-linked polyallylamine or an acid addition salt thereof is obtained by copolymerization of allylammonium dihydrogen phosphate with an acid addition salt of N,N?-diallyl-1,3-diaminopropane in an amount of 5 to 25 mol % with respect to the amount of the allylammonium dihydrogen phosphate, the cross-linked polyallylamine or an acid addition salt thereof having a phosphate adsorption capacity of 2.7 to 5.0 mmol/g; and a degree of swelling of 2.0 to 5.0. The cross-linked polyallylamine or an acid addition salt thereof is useful as a therapeutic or prophylactic agent for hyperphosphatemia.
    Type: Application
    Filed: July 10, 2008
    Publication date: July 29, 2010
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Atsushi Inoue, Kazuharu Suyama, Satoshi Minakami, Mitsuko Miyamoto, Shoichi Itaba
  • Therapeutic method for thrombocytopathy treatment
    Patent number: 6201015
    Abstract: A platelet function increment agent including a prostaglandin I2 derivative as an active ingredient, and a therapeutic method for thrombocytopathy using the same. The platelet function increment agent of the present invention does not induce platelet aggregation, has superior activating action on platelets and is greatly useful as a platelet function increment agent.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: March 13, 2001
    Assignee: Toray Industries, Inc.
    Inventors: Mitsuko Miyamoto, Naohiro Yamada, Atsushi Ohtake, Hisanori Wakita